And I think those two things will get us to the place where we can start having families enrolling in trials because they understand what they're getting themselves into, and it's not this daunting, last resort, scary monster in the corner.

And also you gotta realize within the clinical trial that you have a family that participates in a clinical trial, some of our families are very active socially, right? If they're left that trial with a bad taste in their mouth, that is shared on a huge platform.

Some of our families have 200,000 followers plus, right? And I think what's really important is you say retention, we say support, right? And I think it's two different ways of looking at it.

I think outside of, okay, is the numbers there as far as the studies and how is it fa- like, where's the mon- Outside of the basic business side of pharma, the fact is that we really need to make sure that our families are aware.

When we got the stats that there were so many studies that couldn't find participants, like when we have our families that don't know about any studies, it was like a...

Jimmy, it was crazy.

Why is that the case? And part of it's because of the way that clinicaltrials.gov has been set up.

So talk a little bit about what, what impact looks like for you, and whether it's a story or a data point, a metric, or just a moment that stuck with you that tells that what you're doing is working, and like I said, it's continuing to move us up the ladder.